RPS6 and neoplasm: Immunoblot analysis of tumor samples resected from nude mice revealed that administration of ZSTK474 for two weeks downregulated the PI3K-downstream signaling pathway, as determined by dephosphorylation of AKT and ribosomal S6 protein (Figure 6B).